Tandem Diabetes Care, Inc. has grown revenue 9.6% a year over three years and 11% a year over five. Revenue growth, 3-year annual rate: +9.6% (Medical Devices median +12%). Revenue growth, 5-year rate: +11%, growth has slowed since the five-year average. Years of annual history on file: 14, FY2012 to FY2025, as filed.

TNDMTandem Diabetes Care, Inc.

Healthcare

$16.12+28% 1Y

$16.12

$11.7952 weeks$28.26

Is it growing?

Mixed

Neither accelerating nor breaking down: nothing decisive, though operating margin widening (+16.3 points).

1 good, 1 neutral, 1 without data

Revenue trend+4% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +11% a year.

Margin direction+16.3 points operating

Trailing-twelve-month operating margin, -4.7% now against -21.0% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is TNDM growing?

Tandem Diabetes Care, Inc. has grown revenue 9.6% a year over three years and 11% a year over five.

+9.6%

Revenue growth, 3-year annual rate · Medical Devices median +12% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +11%
Revenue growth, 5-year rate · +9.6% over three · growth has slowed since the five-year average
Years of annual history on file: 14
Years of annual history on file · FY2012 to FY2025, as filed

Details›